OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Thomas Wisniewski

1 Projects | 1 Researchers | $100,000 Invested

2011

New York University

Thomas Wisniewski, MD

Development of peptidomimetic ApoE/Aß Binding Inhibitors as an Effective and Non-toxic Therapeutic Approach for AD

  • Funding Amount: $100,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed